EVE Health Group Limited (EVE) - Net Assets

Latest as of December 2025: AU$3.76 Million AUD ≈ $2.66 Million USD

Based on the latest financial reports, EVE Health Group Limited (EVE) has net assets worth AU$3.76 Million AUD (≈ $2.66 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$4.07 Million ≈ $2.88 Million USD) and total liabilities (AU$307.63K ≈ $217.67K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check EVE Health Group Limited liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets AU$3.76 Million
% of Total Assets 92.44%
Annual Growth Rate 13.44%
5-Year Change -65.13%
10-Year Change 102.84%
Growth Volatility 182.71

EVE Health Group Limited - Net Assets Trend (2004–2025)

This chart illustrates how EVE Health Group Limited's net assets have evolved over time, based on quarterly financial data. Also explore EVE current and non-current assets for the complete picture of this company's asset base.

Annual Net Assets for EVE Health Group Limited (2004–2025)

The table below shows the annual net assets of EVE Health Group Limited from 2004 to 2025. For live valuation and market cap data, see EVE company net worth.

Year Net Assets Change
2025-06-30 AU$3.55 Million
≈ $2.51 Million		 +190.24%
2024-06-30 AU$1.22 Million
≈ $866.05K		 -60.83%
2023-06-30 AU$3.12 Million
≈ $2.21 Million		 -54.93%
2022-06-30 AU$6.93 Million
≈ $4.91 Million		 -31.95%
2021-06-30 AU$10.19 Million
≈ $7.21 Million		 -21.59%
2020-06-30 AU$12.99 Million
≈ $9.19 Million		 +122.15%
2019-06-30 AU$5.85 Million
≈ $4.14 Million		 -20.75%
2018-06-30 AU$7.38 Million
≈ $5.22 Million		 +165.71%
2017-06-30 AU$2.78 Million
≈ $1.97 Million		 +58.60%
2016-06-30 AU$1.75 Million
≈ $1.24 Million		 -33.76%
2015-06-30 AU$2.64 Million
≈ $1.87 Million		 -67.38%
2014-06-30 AU$8.11 Million
≈ $5.74 Million		 -0.89%
2013-06-30 AU$8.18 Million
≈ $5.79 Million		 -64.50%
2012-06-30 AU$23.04 Million
≈ $16.30 Million		 -10.15%
2011-06-30 AU$25.64 Million
≈ $18.14 Million		 +1.95%
2010-06-30 AU$25.15 Million
≈ $17.79 Million		 +9.66%
2009-06-30 AU$22.93 Million
≈ $16.23 Million		 -10.55%
2008-06-30 AU$25.64 Million
≈ $18.14 Million		 +36.51%
2007-06-30 AU$18.78 Million
≈ $13.29 Million		 +214.10%
2006-06-30 AU$5.98 Million
≈ $4.23 Million		 +169.17%
2005-06-30 AU$2.22 Million
≈ $1.57 Million		 +783.85%
2004-06-30 AU$251.35K
≈ $177.84K		 --

Equity Component Analysis

This analysis shows how different components contribute to EVE Health Group Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 3609759800.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (June 2025)

Component Amount Percentage
Common Stock AU$39.74 Million 1118.72%
Other Comprehensive Income AU$-2.50 Million -70.49%
Other Components AU$2.50 Million 70.49%
Total Equity AU$3.55 Million 100.00%

EVE Health Group Limited Competitors by Market Cap

The table below lists competitors of EVE Health Group Limited ranked by their market capitalization.

Company Market Cap
Peraso Inc
NASDAQ:PRSO
 $6.68 Million
Gafisa S.A
SA:GFSA3
 $6.69 Million
PREMIER1 Lithium Ltd
AU:PLC
 $6.69 Million
Lohilo Foods AB
ST:LOHILO
 $6.69 Million
Cambridge Technology Enterprises Limited
NSE:CTE
 $6.68 Million
Syncona Limited
LSE:SYNC
 $6.67 Million
Ansal Properties & Infrastructure Limited
NSE:ANSALAPI
 $6.67 Million
Blende Silver Corp
V:BAG
 $6.67 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in EVE Health Group Limited's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 1,223,992 to 3,552,522, a change of 2,328,530 (190.2%).
  • Net loss of 1,579,955 reduced equity.
  • Share repurchases of 124,013 reduced equity.
  • New share issuances of 1,032,500 increased equity.
  • Other comprehensive income decreased equity by 2,698,192.
  • Other factors increased equity by 5,698,190.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income AU$-1.58 Million -44.47%
Share Repurchases AU$124.01K -3.49%
Share Issuances AU$1.03 Million +29.06%
Other Comprehensive Income AU$-2.70 Million -75.95%
Other Changes AU$5.70 Million +160.4%
Total Change AU$- 190.24%

Book Value vs Market Value Analysis

This analysis compares EVE Health Group Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.04x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 6.11x to 1.04x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2004-06-30 AU$0.00 AU$0.03 x
2005-06-30 AU$0.02 AU$0.03 x
2006-06-30 AU$0.03 AU$0.03 x
2007-06-30 AU$0.05 AU$0.03 x
2008-06-30 AU$0.05 AU$0.03 x
2009-06-30 AU$0.05 AU$0.03 x
2010-06-30 AU$0.04 AU$0.03 x
2011-06-30 AU$0.05 AU$0.03 x
2012-06-30 AU$0.05 AU$0.03 x
2013-06-30 AU$0.02 AU$0.03 x
2014-06-30 AU$0.01 AU$0.03 x
2015-06-30 AU$0.01 AU$0.03 x
2016-06-30 AU$0.00 AU$0.03 x
2017-06-30 AU$0.00 AU$0.03 x
2018-06-30 AU$0.00 AU$0.03 x
2019-06-30 AU$0.00 AU$0.03 x
2020-06-30 AU$0.00 AU$0.03 x
2021-06-30 AU$0.00 AU$0.03 x
2022-06-30 AU$0.00 AU$0.03 x
2023-06-30 AU$0.00 AU$0.03 x
2024-06-30 AU$0.00 AU$0.03 x
2025-06-30 AU$0.03 AU$0.03 x

Capital Efficiency Dashboard

This dashboard shows how efficiently EVE Health Group Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -44.47%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -91.08%
  • • Asset Turnover: 0.42x
  • • Equity Multiplier: 1.16x
  • Recent ROE (-44.47%) is above the historical average (-55.21%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2004 -36.89% 0.00% 0.00x 1.57x AU$-117.85K
2005 -6.01% -417.58% 0.01x 1.12x AU$-355.78K
2006 -4.11% -201.64% 0.02x 1.05x AU$-843.97K
2007 -17.37% -602.04% 0.02x 1.27x AU$-4.18 Million
2008 -18.25% -943.71% 0.01x 1.63x AU$-4.65 Million
2009 -24.14% 0.00% 0.00x 1.56x AU$-5.09 Million
2010 -27.72% -628.39% 0.02x 2.16x AU$-4.61 Million
2011 82.77% 277.36% 0.29x 1.04x AU$18.66 Million
2012 -22.57% 0.00% 0.00x 1.03x AU$-7.50 Million
2013 -212.56% -255571.89% 0.00x 1.01x AU$-18.20 Million
2014 -4.77% -13719.83% 0.00x 1.01x AU$-1.20 Million
2015 -278.66% -3721212.12% 0.00x 1.05x AU$-7.63 Million
2016 -63.04% 0.00% 0.00x 1.10x AU$-1.28 Million
2017 -49.95% -554941.20% 0.00x 1.11x AU$-1.67 Million
2018 -25.47% -9944.99% 0.00x 1.01x AU$-2.62 Million
2019 -45.12% -165.14% 0.18x 1.50x AU$-3.22 Million
2020 -18.47% -103.85% 0.16x 1.09x AU$-3.70 Million
2021 -35.64% -129.63% 0.23x 1.17x AU$-4.65 Million
2022 -77.48% -267.40% 0.25x 1.16x AU$-6.07 Million
2023 -129.41% -173.49% 0.56x 1.32x AU$-4.36 Million
2024 -155.31% -89.08% 0.85x 2.06x AU$-2.02 Million
2025 -44.47% -91.08% 0.42x 1.16x AU$-1.94 Million

Industry Comparison

This section compares EVE Health Group Limited's net assets metrics with peer companies in the Packaged Foods industry.

Industry Context

  • Industry: Packaged Foods
  • Average net assets among peers: $67,748,360
  • Average return on equity (ROE) among peers: -2.67%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
EVE Health Group Limited (EVE) AU$3.76 Million -36.89% 0.08x $6.68 Million
The a2 Milk Company Ltd (A2M) $133.08 Million 22.87% 0.58x $3.44 Billion
Australian Dairy Nutritionals Ltd (AHF) $913.94K 22.60% 0.06x $11.87 Million
Beston Global Food Company Ltd (BFC) $134.14 Million -5.78% 0.09x $4.24 Million
Bega Cheese Ltd (BGA) $171.08 Million 0.00% 1.00x $1.13 Billion
Biome Australia Ltd (BIO) $2.90 Million -57.52% 1.85x $43.32 Million
Bubs Australia Ltd (BUB) $6.05 Million -18.60% 0.14x $63.27 Million
Bioxyne Ltd (BXN) $1.28 Million 15.66% 0.18x $95.09 Million
Cobram Estate Olives Ltd (CBO) $161.05 Million -8.24% 0.90x $1.32 Billion
The Calmer Co International Ltd (CCO) $-87.53K 0.00% 0.00x $4.33 Million
Clover Corporation Ltd (CLV) $67.07 Million 2.26% 0.26x $113.44 Million

About EVE Health Group Limited

AU:EVE Australia Packaged Foods
Market Cap
$6.68 Million
AU$9.44 Million AUD
Market Cap Rank
#27770 Global
#1471 in Australia
Share Price
AU$0.03
Change (1 day)
-3.57%
52-Week Range
AU$0.00 - AU$0.04
All Time High
AU$0.04
Categories
Companies in Australia Packaged Foods
About

EVE Health Group Limited, together with its subsidiaries, engages in the development, retail, and commercialization of health and wellness, and pharmaceutical products. The company lead product is Dyspro, a proprietary pharmaceutical-grade formulation to address dysmenorrhea (menstrual pain); and Libbo, a proprietary pharmaceutical-grade oral dissolving film formulation for the treatment of erect… Read more